Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02845635 · ClinicalTrials.gov registry record
MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 2,200
- Enrollment target
NCT02845635: Completed study, sponsored by Duke University.
NCT02845635 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 2,200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02845635 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 2,200 participants
- Enrollment target
Study Summary
The purpose of this study is to better characterize the fluctuations in multiple sclerosis symptoms and their relationship to medications, to length/extent of disease, and to a variety of physiologic measures.
Interventions
- OTHER Personal history of multiple sclerosis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,200 participants |
| Start Date | 2017-09-29 |
| Est. Completion | 2021-07-28 |
What the finished NCT02845635 record still lists
NCT02845635 is an observational study that tracks outcomes without assigning an intervention. Its 2,200 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Personal history of multiple sclerosis is the first listed.
NCT02845635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02845635 about?
NCT02845635 is a clinical study titled "MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis". The purpose of this study is to better characterize the fluctuations in multiple sclerosis symptoms and their relationship to medications, to length/extent of disease, and to a variety of physiologic measures.
What is the current status of trial NCT02845635?
This trial is currently completed. The enrollment target is 2,200 participants. The study started on 2017-09-29. Estimated completion is 2021-07-28.
What interventions are being tested in trial NCT02845635?
The interventions under investigation include: Personal history of multiple sclerosis (OTHER).
Who is sponsoring clinical trial NCT02845635?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05654207 · 2,200 participants · NA
WeCare: A System of Care for Black Youth
- NCT06144554 · 2,200 participants
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
- NCT06526988 · 2,200 participants · NA
Implementation and Interaction of Clinician And Patient-facing Tools Aiming to Intensify Neurohormonal Medicines for Heart Failure
- NCT06682650 · 2,200 participants · NA
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI